Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Drostanolone

An androgenic steroid derived from dihydrotestosterone (2α-methyl-DHT), described in 1959 and introduced in the United States in 1961 as the propionate ester to treat advanced inoperable breast cancer in women. This family brings together the active ingredient.

Did you know?It was first described in the same scientific paper that introduced oxymetholone; being a DHT derivative, it cannot be converted into oestrogens by aromatase.

Drostanolone PropionateGo to the active ingredient →

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.